{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The \"Medical Device User Fee Stabilization Act of 2005\" amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees for fiscal years 2005, 2006, and 2007. The \"Medical Device User Fee Stabilization Act of 2005\" adjusts device user fees for fiscal years 2005, 2006, and 2007. For fiscal years 2006 and 2007, the Secretary may use unobligated carryover balances from previous years to ensure sufficient fee revenues are available. The Secretary must notify specific committees before using funds as described. Definitions for \"small business\" are clarified, with a threshold of $30,000,000 in gross receipts. Adjustments are made to increase the threshold to $100,000,000 in certain cases. In subsection (e)(2)(A), the threshold is increased from $30,000,000 to $100,000,000. In subsection (g)(1), adjustments are made for fiscal year 2005 based on the appropriated amount. For fiscal year 2005, adjustments are made if the appropriated amount is more than 1 percent less than the amount specified in clause (i). For fiscal year 2005, adjustments are made if the appropriated amount is more than 1 percent less than the specified amount. This involves striking \"2003 through\" and inserting \"2005 and\", as well as inserting \"more than 1 percent\" after \"years, is\". In subsection (h)(3), adjustments are made for fiscal years 2006 and 2007. Annual reports under the Medical Device User Fee and Modernization Act of 2002 are amended to include information on fees paid for different applications and notifications. For fiscal years 2006 and 2007, the report must include information on fees paid for different types of applications from businesses with varying gross receipts. The Secretary must certify that the funds allocated for FDA salaries and expenses related to devices are sufficient. Section 502(u) of the Federal Food, Drug, and Cosmetic Act is amended regarding misbranded devices. The Federal Food, Drug, and Cosmetic Act is amended regarding misbranded devices, specifically reprocessed single-use devices and the requirements for labeling with manufacturer information. The Secretary of Health and Human Services will issue guidance within 180 days to determine when manufacturer information on medical device packaging is not considered \"prominent and conspicuous\". This relates to the reprocessing of single-use devices and labeling requirements under the Federal Food, Drug, and Cosmetic Act. The effective date for Section 502(u) of the Federal Food, Drug, and Cosmetic Act, as amended by the Medical Device User Fee Stabilization Act of 2005, is specified for different types of devices. It applies to reprocessed devices introduced in interstate commerce after the effective date. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}